GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced/ Metastatic Her-2 Positive Breast Cancer
Interventions: DRUG: GQ1001+pyrotinib|DRUG: pyrotinib+capecitabine
Sponsor: Fudan University
Collaborators: GeneQuantum Healthcare (Suzhou) Co., Ltd.